| Literature DB >> 29588569 |
Corrado Gizzi1, Mauro Cellini1, Emilio C Campos1.
Abstract
PURPOSE: To investigate the biomechanical response of the cornea, lamina cribrosa (LC), and prelaminar tissue (PT) to an acute intraocular pressure (IOP) increase in patients with markedly asymmetrical glaucoma and in healthy controls. PATIENTS AND METHODS: A total of 24 eyes of 12 patients with markedly asymmetrical primary open-angle glaucoma (POAG) and 12 eyes of 12 healthy patients were examined with spectral-domain optical coherence tomography (SD-OCT) and ocular response analyzer (ORA) at baseline and during acute IOP elevation by means of an ophthalmodynamometer. The displacement of the LC and PT and the change in corneal hysteresis (CH) and corneal resistance factor (CRF) were evaluated.Entities:
Keywords: asymmetry; biome-chanics; cornea; glaucoma; hysteresis; lamina cribrosa; ophthalmodynamometer
Year: 2018 PMID: 29588569 PMCID: PMC5858548 DOI: 10.2147/OPTH.S151532
Source DB: PubMed Journal: Clin Ophthalmol ISSN: 1177-5467
Figure 1Application of the ophthalmodynamometer on the infratemporal eyelid during an SD-OCT examination.
Abbreviation: SD-OCT, spectral-domain optimal coherence tomography.
Figure 2Vertical distances from the line connecting the Bruch’s membrane ends to the anterior surface of the lamina cribrosa and the prelaminar tissue at baseline (A and C) and during IOP elevation (B and D) in an eye with mild glaucoma.
Abbreviation: IOP, intraocular pressure.
Figure 3Vertical distances from the line connecting the Bruch’s membrane ends to the anterior surface of the lamina cribrosa and the prelaminar tissue at baseline (A and C) and during IOP elevation (B and D) in an eye with severe glaucoma.
Abbreviation: IOP, intraocular pressure.
Figure 4Vertical distances from the line connecting the Bruch’s membrane ends to the anterior surface of the lamina cribrosa and the prelaminar tissue at baseline (A and C) and during IOP elevation (B and D) in a control eye.
Abbreviation: IOP, intraocular pressure.
Demographic data of the participants to the study
| MG–SG patients | Controls | ||
|---|---|---|---|
| Age, years | 59.5±4.6 (53 to 67) | 58.8±6.4 (50 to 73) | 0.298 |
| Gender, M:F | 10:2 | 10:2 | – |
| Ethnicity | 100% caucasian | 100% caucasian | – |
Note:
Mann–Whitney U-test.
Abbreviations: F, female; M, male; MG, mild glaucoma; SG, severe glaucoma.
Values at baseline and comparison among groups
| MG patients | SG patients | Controls | ||||
|---|---|---|---|---|---|---|
| VF MD, dB | −4.21±1.51 (−2.32 to −5.96) | −16.56±5.76 (−12.13 to −21.67) | −1.60±0.65 (−0.68 to −1.98) | 0.024 | 0.006 | 0.002 |
| VF PSD, dB | 3.54±0.87 (2.52 to 5.11) | 10.95±3.51 (6.62 to 15.31) | 1.35±0.24 (1.12 to 1.64) | 0.019 | 0.002 | 0.001 |
| CCT, µm | 517.4±10.16 (510.1 to 539.7) | 514.9±12.6 (496.8 to 540.2) | 517.8±11.41 (500.6 to 540.9) | 0.695 | 0.910 | 0.492 |
| b-IOP, mmHg | 15.4±5.4 (8.3 to 20.8) | 16.6±5.4 (9.8 to 20.7) | 13.7±2.5 (11.4 to 18.6) | 0.425 | 0.425 | 0.250 |
| b-CH, mmHg | 8.62±2.16 (7.2 to 10.4) | 9.30±3.66 (7.1 to 11.6) | 10.96±1.79 (9.7 to 12.2) | 0.970 | 0.095 | 0.596 |
| b-CRF, mmHg | 8.61±2.3 (7.1 to 10.1) | 9.02±1.48 (8.1 to 10.0) | 10.64±1.28 (9.2 to 10.1) | 0.769 | 0.039 | 0.034 |
Notes:
Wilcoxon signed-rank test;
Mann–Whitney U-test.
Abbreviations: b-CH, baseline corneal hysteresis; b-CRF, baseline corneal resistance factor; b-IOP, baseline intraocular pressure; CCT, central corneal thickness; MD, mean deviation; MG, mild glaucoma; PSD, pattern standard deviation; SG, severe glaucoma; VF, visual field.
Baseline IOP with GAT, Tonopen, and ORA
| GAT IOP, mmHg | Tonopen IOP (b-IOP), mmHg | ORA IOPcc, mmHg | ||
|---|---|---|---|---|
| MG patients | 15.4±3.9 (12 to 19) | 15.4±5.4 (8.3 to 20.8) | 16.8±4.9 (10 to 23) | 0.293 |
| SG patients | 16.5±4.8 (10 to 19) | 16.6±5.4 (9.8 to 20.7) | 18.2±5.2 (14 to 23) | 0.187 |
| Controls | 13.3±2.5 (11 to 18) | 13.7±2.5 (11.4 to 18.6) | 14.7±2.9 (10 to 19) | 0.293 |
Note:
Friedman test.
Abbreviations: b-IOP, baseline intraocular pressure; GAT, Goldmann applanation tonometer; MG, mild glaucoma; ORA, ocular response analyzer; SG, severe glaucoma.
IOP during ophthalmodynamometer application and forces applied
| MG patients | SG patients | Controls | ||||
|---|---|---|---|---|---|---|
| i-IOP (OCT), mmHg | 28.3±5.7 (22.2 to 35.1) | 29.2±5.4 (21.8 to 32.4) | 27.4±5.2 (19.7 to 33.1) | 0.402 | 0.387 | 0.429 |
| i-OCT (ORA), mmHg | 27.9±6.5 (19.8 to 38.1) | 28.7±6.4 (18.9 to 32.0) | 25.3±6.7 (17.9 to 31.3) | 0.337 | 0.214 | 0.465 |
| Ophthalmodyn (OCT), Pa | 31.6±2.4 (29 to 36) | 31.2±1.7 (29 to 34) | 30.7±1.1 (28 to 33) | 0.311 | 0.472 | 0.396 |
| Ophthalmodyn (ORA), Pa | 30.3±1.5 (27 to 32) | 30.6±1.5 (28 to 34) | 30.8±1.0 (29 to 32) | 0.347 | 0.294 | 0.286 |
Notes:
Wilcoxon signed-rank test;
Mann–Whitney U-test.
Abbreviations: IOP, intraocular pressure; i-IOP (OCT), IOP on ophthalmodynamometer application during OCT scan; i-IOP (ORA), IOP on ophthalmodynamometer application during ORA measurement; MG, mild glaucoma; ORA, ocular response analyser; OCT, optimal coherence tomography; Ophthalmodyn (OCT), force applied during OCT scan; Ophthalmodyn (ORA), force applied during ORA measurement; SG, severe glaucoma.
Values during IOP elevation and comparison among groups
| MG patients | SG patients | Controls | ||||
|---|---|---|---|---|---|---|
| i-CH, mmHg | 7.23±2.29 (5.8 to 8.7) | 6.92±3.04 (5.1 to 8.9) | 10.59±1.78 (9.3 to 11.8) | 0.519 | 0.011 | 0.003 |
| i-CRF, mmHg | 12.38±3.65 (10.1 to 14.7) | 15.2±2.06 (13.7 to 16.7) | 11.27±1.46 (10.2 to 12.3) | 0.027 | 0.922 | 0.019 |
| LD, µm | 29.08±19.28 (16.8 to 41.3) | −6.58±26.09 (−23.2 to 26.1) | 30.3±10.9 (22.5 to 38.1) | <0.001 | 0.833 | 0.001 |
| PTD, µm | 22.33±33.14 (1.3 to 43.4) | 13.08±17.06 (2.2 to 23.9) | 36.0±17.9 (23.2 to 48.8) | 0.518 | 0.131 | 0.001 |
Notes:
Wilcoxon signed-rank test;
Mann–Whitney U-test.
Abbreviations: i-CH, induced corneal hysteresis; i-CRF, induced corneal resistance factor; i-IOP, induced intraocular pressure; LD, laminar displacement; MG, mild glaucoma; PTD, prelaminar tissue displacement; SG, severe glaucoma.
Intragroup comparison between values at baseline and during IOP increase
| MG
| SG
| Controls
| |||||||
|---|---|---|---|---|---|---|---|---|---|
| Baseline | IOP increase | Baseline | IOP increase | Baseline | IOP increase | ||||
| CH, mmHg | 8.62±2.16 (7.2 to 10.4) | 7.23±2.30 (5.8 to 8.7) | 0.176 | 9.30±3.65 (7.1 to 11.6) | 6.92±3.04 (5.1 to 8.9) | 0.012 | 10.95±1.79 (9.7 to 12.2) | 10.59±1.78 (9.3 to 11.8) | 0.921 |
| CRF, mmHg | 8.61±2.30 (7.1 to 10.1) | 12.38±3.64 (10.1 to 14.7) | 0.002 | 9.02±1.48 (8.1 to 10.0) | 15.20±2.06 (13.7 to 16.7) | 0.002 | 10.64±1.28 (9.2 to 10.1) | 11.27±1.46 (10.2 to 12.3) | 0.275 |
Note:
Wilcoxon signed-rank test.
Abbreviations: CH, corneal hysteresis; CRF, corneal resistance factor; IOP, intraocular pressure; MG, mild glaucoma; SG, severe glaucoma.
Figure 5Scatterplot illustrating the inverse correlation by Spearman’s test between CRF and LD in eyes with severe glaucoma.
Abbreviations: CRF, corneal resistance factor; LD, laminar displacement.